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IMPORTANCE Adult mood disorders are often preceded by behavioral and emotional
problems in childhood. It is yet unclear what explains the associations between childhood
psychopathology and adult traits.
OBJECTIVE To investigate whether genetic risk for adult mood disorders and associated traits
is associated with childhood disorders.
DESIGN, SETTING, AND PARTICIPANTS Thismeta-analysis examined data from 7 ongoing
longitudinal birth and childhood cohorts from the UK, the Netherlands, Sweden, Norway, and
Finland. Starting points of data collection ranged from July 1985 to April 2002. Participants
were repeatedly assessed for childhood psychopathology from ages 6 to 17 years. Data
analysis occurred from September 2017 to May 2019.
EXPOSURES Individual polygenic scores (PGS) were constructed in children based on
genome-wide association studies of adult major depression, bipolar disorder, subjective
well-being, neuroticism, insomnia, educational attainment, and bodymass index (BMI).
MAIN OUTCOMES ANDMEASURES Regressionmeta-analyses were used to test associations
between PGS and attention-deficit/hyperactivity disorder (ADHD) symptoms and
internalizing and social problemsmeasured repeatedly across childhood and adolescence and
whether these associations depended on childhood phenotype, age, and rater.
RESULTS The sample included 42 998 participants aged 6 to 17 years. Male participants varied
from 43.0% (1040 of 2417 participants) to 53.1% (2434 of 4583 participants) by age and
across all cohorts. The PGS of adult major depression, neuroticism, BMI, and insomnia were
positively associated with childhood psychopathology (β estimate range, 0.023-0.042 [95%
CI, 0.017–0.049]), while associations with PGS of subjective well-being and educational
attainment were negative (β, −0.026 to −0.046 [95% CI, −0.020 to −0.057]). There was no
moderation of age, type of childhood phenotype, or rater with the associations. The
exceptions were stronger associations between educational attainment PGS and ADHD
compared with internalizing problems (Δβ, 0.0561 [Δ95% CI, 0.0318-0.0804]; ΔSE, 0.0124)
and social problems (Δβ, 0.0528 [Δ95% CI, 0.0282-0.0775]; ΔSE, 0.0126), and between BMI
PGS and ADHD and social problems (Δβ, −0.0001 [Δ95% CI, −0.0102 to 0.0100]; ΔSE,
0.0052), compared with internalizing problems (Δβ, −0.0310 [Δ95% CI, −0.0456 to
−0.0164]; ΔSE, 0.0074). Furthermore, the association between educational attainment PGS
and ADHD increased with age (Δβ, −0.0032 [Δ 95% CI, −0.0048 to −0.0017]; ΔSE, 0.0008).
CONCLUSIONS AND RELEVANCE Results from this study suggest the existence of a set of
genetic factors influencing a range of traits across the life span with stable associations
present throughout childhood. Knowledge of underlying mechanismsmay affect treatment
and long-term outcomes of individuals with psychopathology.
JAMA Psychiatry. doi:10.1001/jamapsychiatry.2020.0527
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L ongitudinal studies indicate that the onset ofmooddis-orders in adulthood, including depression and bipolardisorder (BD), is often preceded by childhood prob-
lems. These include not only internalizing problems, such as
depression and anxiety,1,2 but also externalizing traits, such
as attention-deficit/hyperactivity disorder (ADHD) and
aggression.3-5 Moreover, both in prospective and retrospec-
tive studies, behavioral andemotional problemsduring child-
hood and adolescence have been associated with other adult
outcomes that are associated with adult mood disorders, in-
cluding educational attainment (EA),6-9 insomnia,10,11 subjec-
tive well-being (SWB),12 personality,13-16 and body mass in-
dex (BMI; calculated asweight in kilogramsdividedbyheight
in meters squared).17-19
Both twin/family and molecular genetic studies have re-
ported heritability20-22 and stability23-25 of psychopathology
over time. Studies of BD in high-risk families also show that
children of parentswith BD are susceptible to psychiatric dis-
orders and symptoms in childhood,26 adolescence, and early
adulthood.27,28 These results suggest that genetic factorsmay
underlie the persistence of symptoms or the transition from
one disorder to another between childhood and adulthood.
Polygenic score (PGS) analyses enable the examination of the
genetic associationbetween adult traits and childhood symp-
toms of psychopathology.
Polygenic scores are aggregate scoresof an individual’s ge-
netic risk for a trait, calculated by summing risk alleles froma
discovery genome-wide association study (GWAS), weighted
by their effect sizes.29 For complex (ie, polygenic) traits influ-
enced by many genetic variants, PGS summarize genetic risk
across loci that are not individually significant in a GWAS. A
statisticallysignificantassociationbetweenmeasuredtraitsand
PGSbased on another trait suggests a shared genetic etiology.
Results of studies using PGS to investigate the association of
childhood psychopathologywithmooddisorders and associ-
ated traits vary.Analyses investigatingdepressionandBDPGS
have found no evidence of associations with emotional and
behavior problems during childhood and adolescence, al-
though there is evidence of association between depression
PGS and emotional problems in adulthood.30-32 Associations
betweenPGSofEAandADHDorattentionproblemshavebeen
more consistent,withmultiple studies30,32-34 showing strong
genetic associations betweenEAandADHDor attentionprob-
lems in childhood and adolescence.
The last 2 years have seen ever-larger GWAS for traits, in-
cludingmajordepression (MD),35,36BD,37EA,38andBMI,39con-
sequently increasing accuracy of PGS.40 Combined with the
substantial increase in individuals genotyped in large longi-
tudinal childhood cohorts that assess psychopathology, this
provides anopportunity to rigorously investigatewhether ge-
netic factorsunderlie theassociationsbetweenchildhoodpsy-
chopathology and adult mood disorders and associated non-
psychiatric traits (EA, insomnia, SWB, neuroticism, and BMI)
anddeterminewhether this associationdependsonage.Using
7 childhood population-based cohorts, we studied 42998 in-
dividuals with repeatedmeasures of ADHD symptoms, inter-
nalizing, and social problems.Weperformedmeta-analyses to
test whether PGS of adult traits are associated with child-
hood and adolescent psychopathology and whether this as-
sociation depends on various factors, including age, type of
psychopathology, type of scale used to measure psychopa-
thology, and the informant.
Methods
Participants andMeasures
We obtained self-rated or maternal-rated measures of ADHD
symptoms, internalizing,andsocialproblemsfrom7population-
based cohorts (Table 1). Data collection was approved by each
cohort’s local institutional review or ethics board, waiving the
need for informed consent for this study. The starting points
ofdata collectionvaried, ranging fromJuly 1985 toApril 2002.
Data analysis was performed from September 2017 to May
2019. Cohort descriptions can be found in the eAppendix 2 in
the Supplement.
Genotyping and Polygenic Scores
Genotyping and quality control were performed by each co-
hort, followingcommonstandards (eAppendix2 in theSupple-
ment). In each cohort, PGS were constructed for the follow-
ingadult traits:MD,35BD,37 SWB,41 neuroticism,41 insomnia,42
EA,38 and BMI.39 Height39 was included as a control pheno-
type (eTable 1 in the Supplement contains the GWAS discov-
ery sample size for each trait). To avoid overlap between dis-
covery and target samples, summary statistics omitting the
target cohort or cohorts were used. Analyses were limited to
individuals of European ancestry.
Polygenic scoreswere estimated using LDpred, amethod
that takes into account the level of linkage disequilibriumbe-
tweenmeasuredsingle-nucleotidevariants (SNVs;oftencalled
single-nucleotide polymorphisms) to avoid inflation of effect
sizes.43 The method LDpred requires the inclusion of prior
probabilities corresponding to the fractionof SNVs thought to
becausal,whichallows for testingvaryingproportionsofSNVs
associatedwith theoutcomeof interest.We thus testeda range
of priors (0.75, 0.50, 0.30, 0.10, and 0.03) to assess the prior
at which assessment was optimal. We restricted analyses to
common variants, using SNV inclusion criteria of minor al-
lele frequency greater than 5% and imputation quality of R2
greater than 0.90.
Key Points
Question Do genetic factors underlie the association between
childhood psychopathology and adult mood disorders and
associated traits?
Findings This meta-analysis of longitudinal cohorts, which
includes data on 42 998 participants, revealed significant
associations between childhood psychopathology and adult
polygenic scores of major depression, subjective well-being,
neuroticism, insomnia, educational attainment, and bodymass
index but not bipolar disorder.
Meaning Per this analysis, shared genetic factors exist between
childhood psychopathology traits from age 6 years onwards and
adult depression and associated traits.
Research Original Investigation Genetic Associations of Childhood Psychopathology and Adult Depression and Associated Traits in 42 998 Individuals
E2 JAMAPsychiatry Published online April 15, 2020 (Reprinted) jamapsychiatry.com
Downloaded From: https://jamanetwork.com/ by a Erasmus MC - Univ of Rotterdam User  on 05/06/2020
Cohort-Specific Association Analyses
In each cohort, associations between childhood psychopa-
thologyandadult traitswereestimatedby regressingeachout-
comemeasure (ie, ADHDsymptoms, internalizing, and social
problems) stratified by age and rater, on the calculated PGSof
the8adult traits at the 5priors.Awidevarietyof surveyswere
used to further characterize the cohort.44-50
Where cohorts included related individuals, regressions
were performed using the exchangeable model in general-
ized estimating equations to correct for relatedness in
samples.51 Scales were coded such that higher scores re-
flectedmore childhood problems. Both childhood psychopa-
thology scores and PGSwere standardized to amean of 0 and
anSDof 1, allowing for comparable βs across cohorts. Sex, age,
batch effects, and genetic principal components (which cor-
rect for population stratification)were included as covariates
in the regression (eAppendix 2 in the Supplement).
MultivariateMeta-analyses
Meta-analyses were performed using the metafor package in
Rversion 3.6.0 (RFoundation for Statistical Computing).52 To
obtain theprior that provided the strongest estimateof the as-
sociation with overall childhood psychopathology, we per-
formed a random-effects meta-analysis for each of the 5 pri-
ors foreachadult-traitPGS.Specifyingrandomeffectsaccounts
for heterogeneity in the true associations attributable to fac-
tors that contribute to sample variation across cohorts, such
as differences in measurements and sample characteristics.
Subsequentanalyses for eachadult traitwereconductedbased
on the selected prior from the previous analysis (ie, the one
that provided the highest estimate of the association). As a
sensitivity check, we repeated all analyses using a prior of
0.50 and compared these results to those using the prior
with the highest estimate. We selected the prior of 0.50,
because it represents a reasonable estimation of the propor-
tion of associated SNVs across the different types of com-
plex traits we tested.
To correct for dependency in the outcome variables
attributable to repeatedmeasuresof the same individualsover
time, we specified the variance-covariance matrix between
their sampling errors. Because errors were assumed to be
independent between cohorts, we combined variance-
covariance matrices across cohorts by setting correlations
between cohorts to0 in thematrix, further accounting for dif-
ferences between cohorts.53 To test whether the error covari-
ance matrix alone suitably accounted for differences be-
tween cohorts, we applied for each adult trait an analysis of
variance (ANOVA) test to comparemodelswith the randomef-
fectsdroppedwith thosewhere theywere specifiedalongwith
the error covariance matrix.
Subsequent meta-analyses to test the association be-
tween each adult-trait PGS and overall childhood psychopa-
thology (ie,all 3childhoodmeasuresanalyzed jointly)wereper-
formedon the reducedmodel (no randomeffects), if dropping
them did not result in a significant loss of fit compared with
the full model (random effects plus error covariancematrix).
Table 1. Sample Characteristics
Cohort
Approximate Age
Groups, y Scale(s)
Phenotype(s)
Measured Rater
Sample
Size
Avon
Longitudinal
Study of
Parents and
Children
7, 10, 12, 14, 16 Strength and Difficulties
Questionnaire
ADHD
symptoms,
internalizing
problems, social
problems
Maternal 6502
Child and
Adolescent
Twin Study in
Sweden
9, 12, 15 Autism-Tics, ADHD and Other
Comorbidities Inventory, Screen for
Child Anxiety Repated Emotional
Disorders, Short Mood and Feelings
Questionnaire, Strength and
Difficulties Questionnaire
ADHD
symptoms,
internalizing
problems, social
problems
Maternal,
self
11 039
Generation R 6, 10 Achenbach System of Empirically
Based Assessment (Child Behavior
Checklist)
ADHD
symptoms,
internalizing
problems, social
problems
Maternal 2438
Norwegian
Mother and
Child Cohort
Study
8 Screen for Child Anxiety Related
Emotional Disorders, Short Mood
and Feelings Questionnaire, Rating
Scale for Disruptive Behavior
Disorders
ADHD
symptoms,
internalizing
problems
Maternal 4583
Northern
Finland Birth
Cohort of
1986
16 Achenbach System of Empirically
Based Assessment (Youth Self
Report)
ADHD
symptoms,
internalizing
problems, social
problems
Self 3409
Netherlands
Twin Register
7, 10, 12, 14, 17 Achenbach System of Empirically
Based Assessment (Child Behavior
Checklist and Youth Self Report)
ADHD
symptoms,
internalizing
problems, social
problems
Maternal,
self
5501
Twins Early
Development
Study
7, 8, 9, 12, 14, 16 Strength and Difficulties
Questionnaire, Conners’ Parent
Rating Scale
ADHD
symptoms,
internalizing
problems, social
problems
Maternal,
self
9526
Abbreviation:
ADHD, attention-deficit/
hyperactivity disorder.
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We also tested the association between the PGS and each in-
dividual childhood psychopathology measure.
Because both the childhood outcomes, and PGS mea-
suresarecorrelated,weestimated theeffectivenumberof tests
between both sets of variables under the assumption that
they are nonindependent.54,55 We corrected the meta-
analysis results for multiple testing by applying Bonferroni
correction (P = .05/number of tests) to the effective number
of tests (2015.04 effective tests; α = 2.48 × 10−5) (eTable 2 in
the Supplement).
Multimodel Inference Analyses to IdentifyModerators
Toascertainwhether thevariables age, typeof childhoodpsy-
chopathology (ie, ADHD symptoms, internalizing problems,
or socialproblems),measurement instrument (eg,Strengthand
Difficulties Questionnaire,44 Achenbach System of Empiri-
callyBasedAssessment48), and rater (ie,maternalor self)mod-
erated association between childhood psychopathology and
adult-trait PGS, we performed multimodel inference analy-
ses using the glmulti package in R version 3.6.0.56 The gl-
multipackageallows thedefinitionofa function that takes into
account all potential moderators and generates all possible
models for the associationof interest, returning thebestmod-
elsbasedonaspecified informationcriterion; inour study, this
was Akaike information criterion.57 Furthermore, it provides
parameter estimates basedonall possiblemodels, rather than
a single-top model, while considering the relative impor-
tance of eachpotentialmoderator byweighting them.The av-
eragedmodelavoids relyingtoostronglyonasinglebestmodel.
In summary, for eachadult-trait PGS,weselected theprior
thatprovide thestrongestestimateof itsassociationwithchild-
hood psychopathology by performing random-effects meta-
analyses at each prior. This was followed by ANOVA tests to
determine whether our error covariance matrix suitably ac-
counted for differences between cohorts.We then performed
multivariatemeta-analyses testing the associations of PGS of
adult traits with childhood psychopathology at all ages. Fi-
nally, we performedmultimodel inference analyses to ascer-
tainwhethermoderatorsaffectedtheassociationbetweeneach
adult-trait PGS and childhood psychopathology.
Results
The 7 included cohorts combinedparticipants from theNeth-
erlands, UK, Sweden, Norway, and Finland in a combined
sample of 42998 unique participants aged 6 to 17 years old.
Thepercentageofmaleparticipants ranged from43.0% (1040
of 2417 participants) to 53.1% (2434 of 4583 participants) by
age and across all cohorts.
Cohort-Specific Association Analyses
Cohort-specific descriptive statistics and correlation matri-
ces of the 3 psychopathologymeasures, ADHDsymptoms, in-
ternalizing problems, and social problems are described in
eTables 3, 4, 5, 6, 7, 8, and 9 in the Supplement. Correlation
matrices show the observed variability or stability of child-
hoodpsychopathologyover time. Basedon cohortswithmul-
tiple or consistent measures of psychopathology across de-
velopment,weobservedmoderatecorrelationsacrossdifferent
ages. Estimates were highest for measurements of the same
trait at adjacent ages, around 0.50, and lowest between self-
rated and maternally rated measures, around 0.20. The re-
sults of the univariate analyses in each cohort are displayed
in eTables 10, 11, 12, 13, 14, 15, and 16 in the Supplement.
Meta-analyses
Random-effects meta-analyses corresponding to the 5 priors
showed that the prior that provided the strongest association
estimates were 0.75 for EA and BMI; 0.50 for MD, insomnia,
andheight;0.30 forneuroticism;0.10 forBD;and0.03 forSWB
(eTable 17 in the Supplement). A reducedmodel (errormatrix
alone) was used in themultivariate and subsequent analyses
for all traits except for theEAandBMIPGS, forwhichweused
the full model (random effect plus the error covariance ma-
trix). Thiswas becauseANOVA tests comparing the fullmodel
with the reduced model suggested that the error covariance
matrix alone insufficiently accounted for differences be-
tween cohorts (ANOVA results, eTable 18 in the Supplement).
Subsequentmeta-analysesof theassociationbetweenPGS
of each adult trait andoverall childhoodpsychopathology (all
3 childhoodmeasures in the samemodel) showed that the di-
rections of associations were as expected (Figure 1). Signifi-
cant positive associations were observed for PGS of MD
(β, 0.042 [95% CI, 0.036-0.049]; SE, 0.003; P = 2.48 × 10−37;
R2, 0.002), neuroticism (β, 0.035 [95% CI, 0.029-0.042]; SE,
0.003;P = 1.22 × 10−26;R2, 0.001), insomnia (β,0.023 [95%CI,
0.017-0.030]; SE,0.003;P = 2.36 × 10−12;R2,0.0005), andBMI
(β, 0.035 [95% CI, 0.025-0.046]; SE, 0.005; P = 2.23 × 10−11;
R2, 0.001), while associations for SWB (β, −0.026 [95% CI,
−0.020 to−0.033]; SE,0.003;P = 1.92 × 10−15;R2, 0.0006)and
EA (β, −0.046 [95% CI, −0.035 to −0.057]; SE, 0.006;
P = 6.74 × 10−17; R2, 0.002) were negative. There was no evi-
dence for association with BD PGS (β, 0.005 [95% CI, −0.001
to 0.012]; SE, 0.003; P = .11; R2, 2.50 × 10−5). No associations
were found with the PGS of height.
Moderators
Usingmodel averaging, we considered the effect of 4modera-
tors (ie, outcome, age, measurement instrument, and rater)
across all possible models. Using a P value threshold of .0125
(α = .05/number of moderators), we found evidence of mod-
eration for EA andBMIPGS (Table 2). The association between
EAPGSandchildhoodpsychopathologyvariedasa functionof
outcome,rater,andage.TheEAPGSwereassociatedwithADHD
symptomsbutnot internalizingproblems(Δβ,0.0561 [Δ95%CI,
0.0318-0.0804]; ΔSE, 0.0124) or social problems (Δβ, 0.0528
[Δ95% CI, 0.0282-0.0775]; ΔSE, 0.0126); Figure 1). Addition-
ally, the association betweenADHD symptoms andEAPGS in-
creasedwithage (Δβ,−0.0032 [Δ95%CI,−0.0048 to−0.0017];
ΔSE,0.0008) inmaternal ratings,while self-ratings showedthe
opposite (Δβ, 0.0463 [Δ95% CI, 0.0315-0.0611]; ΔSE, 0.0075).
However, the influence of rater on the associations appears to
be driven by a single outlier aged around 17 years in the self-
reported data (Figure 2). The association between BMI PGS
and childhood psychopathology also varied across outcomes.
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AssociationswerestrongestwithADHDandsocialproblems(Δβ,
−0.0001 [Δ95%CI, −0.0102 to 0.0100]; ΔSE, 0.0052), com-
pared with internalizing problems (Δβ, −0.0310 [Δ95%
CI, −0.0456 to −0.0164]; ΔSE, 0.0074). Moderators did not in-
fluenceassociationsbetweentheotheradult-traitPGSandchild-
hood psychopathology (eTable 19 in the Supplement).
Sensitivity Analyses
Using a prior of 0.50 sensitivity analyses showed similar re-
sults to the main analyses, except for the moderation of
outcomeontheassociationwithBMIPGS(intercept:β,0.0439;
SE, 0.0087 [95% CI, 0.0269-0.0609]; internalizing prob-
lems:Δβ,−0.0257;ΔSE,0.0130[Δ95%CI,−0.0512 to−0.0003];
social problems: Δβ, −0.0018; ΔSE,0.0055 [Δ95%CI, −0.0126
to0.0089]; eFigure in the Supplement).While thiswasnomi-
nally significant (P = .047), it didnot remainafter adjusting for
the 4 moderators tested (α = .0125; eTable 20 in the Supple-
ment).Results fromthemainanalyses also remained the same
when all meta-analyses included random effects.
Discussion
We investigated genetic associations between childhoodpsy-
chopathology and adultmood disorders and associated traits
over time. Using results of well-powered GWAS meta-
analyses of adult traits, we calculated PGS in what is, to our
knowledge, the largest childhood target sample todate for this
typeof study (N = 42998).We revealed strong evidenceof as-
sociations of PGS for adult MD, SWB, neuroticism, insomnia,
Figure 1. MultivariateMeta-analysis Estimates of the Associations Between Adult Traits and Overall Childhood
Psychopathology
–0.12 0.09–0.06 –0.03 0 0.03 0.06
β (95% CI)
–0.09
Source
Major depression
β (95% CI)
Combined 0.0423 (0.0358 to 0.0488)
ADHD symptoms 0.0495 (0.0407 to 0.0583)
Internalizing problems 0.0416 (0.0334 to 0.0497)
Social problems 0.0403 (0.0309 to 0.0497)
Bipolar disorder
Combined 0.0053 (–0.0012 to 0.0119)
ADHD symptoms 0.0016 (–0.0072 to 0.0104)
Internalizing problems 0.0103 (0.0021 to 0.0185)
Social problems 0.0043 (–0.0053 to 0.0138)
Subjective well-being
Combined –0.0264 (–0.0329 to –0.0199)
ADHD symptoms –0.0179 (–0.0266 to –0.0091)
Internalizing problems –0.0335 (–0.0417 to –0.0253)
Social problems –0.0254 (–0.0348 to –0.0160)
Neuroticism
Combined 0.0352 (0.0288 to 0.0417)
ADHD symptoms 0.0292 (0.0205 to 0.0379)
Internalizing problems 0.0471 (0.0390 to 0.0553)
Social problems 0.0285 (0.0192 to 0.0378)
a
a
a
a
a
a
a
a
a
a
a
Insomnia
Combined 0.0232 (0.0167 to 0.0297)
ADHD symptoms 0.0304 (0.0216 to 0.0392)
Internalizing problems 0.0193 (0.0112 to 0.0273)
Social problems 0.0213 (0.0118 to 0.0307)
Educational attainment
Combined –0.0461 (–0.0569 to –0.0353)
ADHD symptoms –0.0880 (–0.1040 to –0.0720) a
Internalizing problems –0.0256 (–0.0398 to –0.0114)
Social problems –0.0243 (–0.0407 to –0.0079)
Body mass index
Combined 0.0354 (0.0251 to 0.0458)
ADHD symptoms 0.0523 (0.0434 to 0.0612)
Internalizing problems 0.0138 (0.0009 to 0.0268)
Social problems 0.0478 (0.0352 to 0.0604)
Height
Combined –0.0086 (–0.0155 to –0.0017)
ADHD symptoms –0.0091 (–0.0185 to –0.0002)
Internalizing problems –0.0106 (–0.0192 to –0.0020)
Social problems –0.0063 (–0.0163 to –0.0036)
a
a
a
a
a
a
a
a
Bars represent confidence intervals
corresponding to α = .05.
ADHD indicates attention-deficit/
hyperactivity disorder. aIndicates
significance after correction for
multiple testing (α = 2.48 × 10−5).
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EA, and BMI with childhood ADHD symptoms, internalizing
problems, and social problems. We found no evidence of as-
sociations between BD PGS and childhood psychopathology.
In addition,we foundnoevidenceof themoderators age, out-
come, measurement instrument, and rater on these associa-
tions, except forEAPGSandBMIPGS.WhileEAPGSwasmore
strongly associatedwithADHDsymptoms comparedwith the
2 other outcomes, BMI PGS was more strongly associated
with ADHD symptoms and social problems than with inter-
nalizing problems. The association between EA PGS and
ADHD symptoms increased with age and was stronger for
maternal-rated ADHD symptoms compared with self-rated
ADHD symptoms.
Our results indicate a consistent pattern of genetic asso-
ciationsbetweenPGSof adult depressionandassociated traits
and childhoodpsychopathology across age. This hasnot been
observed previously, which is likely partly attributable to the
increased power of our larger discovery and target samples
comparedwithprevious studies.31,32Moreover, previous stud-
ies focused on separate childhood phenotypes58,59 as op-
posed to our approach of simultaneously analyzing multiple
childhood problems at different ages. Consistent genetic as-
sociations across age suggest a set of genetic variants that in-
fluence a range of traits across the life span.
The exceptions to these consistent associations were EA
and BMI PGS, which showedmoderation on the associations
Table 2. Model-AveragedModerator Effects for Educational Attainment and BodyMass Indexa
Variable Estimate (SE) 95% CI z value P value Importance
Educational
attainment
Intercept −0.0770 (0.0092) −0.0950 to −0.0591 −8.4072 4.20 × 10−17b 1.0000
Self-rating 0.0463 (0.0075) 0.0315 to 0.0611 6.1370 8.41 × 10−10b 1.0000
Age −0.0032 (0.0008) −0.0048 to −0.0017 −4.0563 4.99 × 10−5b 0.9896
Outcome
measures
Internalizing
problems
0.0561 (0.0124) 0.0318 to 0.0804 4.5239 6.07 × 10−6b 0.9606
Social
problems
0.0528 (0.0126) 0.0282 to 0.0775 4.2076 2.58 × 10−5b 0.9606
Scale
A-TAC 0.0008 (0.0016) −0.0023 to 0.0039 0.4956 0.6202 0.0194
Conners’
Parent Rating
Scale
0.0008 (0.0016) −0.0023 to 0.0039 0.4898 0.6243 0.0194
RS-DBD 0.0007 (0.0015) −0.0022 to 0.0037 0.4737 0.6357 0.0194
SCARED 0.0001 (0.0004) −0.0007 to 0.0008 0.1861 0.8524 0.0194
SDQ −0.0002 (0.0004) −0.0010 to 0.0007 −0.4316 0.6660 0.0194
SMFQ −0.0008 (0.0016) −0.0038 to 0.0023 −0.4923 0.6225 0.0194
BMI
Intercept 0.0468 (0.0064) 0.0343 to 0.0593 7.3531 1.94 × 10−13b 1.0000
Outcome
measure
Internalizing
problems
−0.0310 (0.0074) −0.0456 to −0.0164 −4.1744 2.99 × 10−5b 0.9374
Social
problems
−0.0001 (0.0052) −0.0102 to 0.0100 −0.0192 0.9847 0.9374
Self-rated −0.0011 (0.0022) −0.0055 to 0.0033 −0.5068 0.6123 0.0923
Age 7.48 × 10−6
(2.32 × 10−5)
−3.80 × 10−5 to 0.0001 0.3223 0.7473 0.0195
Scale
A-TAC −1.42 × 10−9
(3.35 × 10−9)
−7.99 × 10−9 to
5.14 × 10−9
−0.4241 0.6715 8.21 × 10−8
Conners’
Parent Rating
Scale
2.77 × 10−12
(1.62 × 10−9)
−3.18 × 10−9 to
3.19 × 10−9
0.0017 0.9986 8.21 × 10−8
RS-DBD −1.03 × 10−9
(3.12 × 10−9)
−7.15 × 10−9 to
5.09 × 10−9
−0.3290 0.7422 8.21 × 10−8
SCARED −3.32 × 10−9
(6.90 × 10−9)
−1.68 × 10−8 to
1.02 × 10−8
−0.4809 0.6306 8.21 × 10−8
SDQ −1.05 × 10−9
(2.47 × 10−9)
−5.90 × 10−9 to
3.80 × 10−9
−0.4260 0.6701 8.21 × 10−8
SMFQ 2.69 × 10−10
(1.67 × 10−9)
−3.00 × 10−9 to
3.54 × 10−9
0.1612 0.8720 8.21 × 10−8
Abbreviations: A-TAC, Autism-Tics,
ADHD, and Other Comorbidities
Inventory; BMI, bodymass index
(calculated as weight in kilograms
divided by height in meters squared);
RS-DBD, Rating Scale for Disruptive
Behavior Disorders; SCARED, Screen
for Child Anxiety Related Emotional
Disorders; SDQ, Strength and
Difficulties Questionnaire;
SMFQ, Short Mood and Feelings
Questionnaire.
a The intercept estimate contains
information from the reference
variable of eachmoderator, selected
in alphabetical order or with the
lowest value, in the case of
numerical moderators. Hence the
intercept reflects the association
estimate between educational
attainment or BMI and Achenbach
System of Empirically Based
Assessment measured, maternally
rated attention problems at
approximately age 6 years. The
other estimates show the change in
association estimates depending on
themoderator variable. The
importance value for each
moderator represents their overall
support across all models.
Moderators present in multiple
models with large weights will have
higher importance, and the closer
this value is to 1, the more important
themoderator is for the association
being considered.
bValues were significant when
adjusted for 4moderators
(α = .05/4 = .0125).
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by thedifferent types of childhoodoutcome.While bothwere
genetically associated with ADHD in accordance with previ-
ous research,30,33,34,58 theywerenot associatedwith internal-
izing problems, or social problems, in the case of EA. The lack
of associationwith internalizingproblemswas somewhat un-
expected, givengenetic correlationspreviously found forBMI
and EAwith adult MD.35,36 These results suggest that genetic
associations between EA and BMI andMDmay becomemore
apparent after adolescence,while they are alreadypresent for
childhood ADHD and social problems (for BMI).
We did not identify associations between BD PGS and
childhood psychopathology. This is intriguing because mod-
erate genetic correlations with BD have been observed for
MD and ADHD, as well as other behavioral-cognitive pheno-
types, such as SWB and EA.21 However, previous analyses of
BD PGS also found no associations with continuous measures
of psychopathology in childhood32,60 or adolescence.61 These
results may be explained by less powerful BD GWAS com-
pared with MD and other traits, which might result in under-
powered PGS. Nevertheless, the lack of association with BD
PGS may also suggest that genetic risk for BD does not mani-
fest until later in development, but given the higher preva-
lence rates of childhood psychopathology in offspring of
parents with BD, this seems less likely.28,62,63 It will be inter-
esting to see if the observation holds as more powerful GWAS
become available for BD.
Limitations
A limitation of our study is that analyses are limited to Euro-
pean ancestry, and therefore results are not generalizable to
populations of differing ancestry. Second, associations be-
tweenPGS and childhoodpsychopathologymeasuresmaybe
confounded by unaccounted passive gene-environment cor-
relations, an association between a child’s genotype and
familial environment resulting from parents providing en-
vironments that are influenced by their own (parental)
genotypes.64,65Consequently,associationsobservedwithadult
PGS may be the result of both direct and indirect (environ-
mentally-mediated) genetic effects. Third, dropoutmayhave
influenced our results. Previous analyses in longitudinal co-
horts have reported negative associations between PGS for
schizophrenia, ADHD, and depression and participation in
childhood and adolescence.66,67 Nonparticipation in adoles-
cence is also associated with higher psychopathology scores
at earlier ages.53 These results suggest that individuals with
higher genetic risk for psychiatric disorders and higher
childhoodpsychopathology aremore likely todropout of lon-
gitudinal studies. Genetic associations and the magnitude of
associations reported may therefore be underestimated. Fi-
nally, because we combined data from different cohorts, we
introducedheterogeneity in the assessment of childhoodpsy-
chopathology. However, themeta-regression showed in gen-
eral, consistent effect sizes across scales and raters. More-
over, combining multiple cohorts resulted in a large sample
size, increasingstatisticalpowercomparedwithpreviousstud-
ies, which is a strength of this study.
Conclusions
The general lack of an influence of age and type of childhood
psychopathology onour identified associations supports evi-
dence of a common genetic psychopathology factor that re-
mains stable acrossdevelopment.68Polygenic scoresby them-
selves arenot sufficient to identify individual children at high
risk for persistence (they explain <1%of the variance in child-
hoodpsychopathology in this study).Nevertheless, these find-
ings are ofmajor importance because the individualswho are
affected across the life spanwith consequences on other out-
comes, such as EA and BMI, should be the focus of attention
for targeted treatment. Furthermore, PGS could be combined
with other risk factors for risk assessment in clinical samples,
as was recently done for psychosis risk using schizophrenia
PGS.69 Future studies focusing on samples from high-risk
populationsarewarranted to investigatewhetherPGS foradult
traits, together with other variables, can be used to build risk
profiles with reasonable accuracy. These may allow for the
stratificationof children intohigh-risk and low-risk groups for
persistence, aswell as testwhether early interventionormore
intense treatments for the former group can prevent poor
outcomes.70
In conclusion, we demonstrate the power of combining
genetic longitudinal population data to elucidate develop-
mental patterns in psychopathology. Our study provides
novel evidence for the presence of shared genetic factors
between childhood psychopathology and depression and
associated adult traits, as well as their stability across devel-
opment. Insight into these associations may aid identifi-
cation of children at risk for a relatively chronic course of ill-
ness, ultimately facilitating targeted treatment to this
vulnerable group.
Figure 2. Moderator Effects of Age and Rater on the Association
Between Educational Attainment Polygenic Scores and
Attention-Deficit/Hyperactivity Disorder
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Each point represents β estimates from univariate analyses of the association
between educational attainment polygenic scores and attention-deficit/
hyperactivity disorder symptoms at different ages. Overall, the negative
association becomes stronger with increasing age (Table 2). The gray shadow
around the trend line represents the 95% CI of the age effect size.
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